PAJO, October 2010, Vol. 3, No. 3
Original article
Clinico-pathological study and treatment results of 1009 operable breast cancer cases:Experience of NCI Cairo University
Hesham El Hosseiny
PAJO 2010, 3(3): 6-13
Proteomic Analysis of Human plasma protein. High expression of haptoglobin using two dimensional gel electrophoresis in Infiltrating Ductal Carcinomas of the Breast.
Bechr Hamrita
PAJO 2010, 3(3): 14-17
BRCA1 and EGFR as prognostic biomarkers in triple negative metastatic breast cancer patients treated with cisplatin plus docetaxel
Lobna R. Ezz
PAJO 2010, 3(3): 18-25
Weekly Cisplatin and Docetaxel plus Concomitant Boost Concurrently with Radiation Therapy in the Treatment of Locally Advanced Head And Neck Cancer: Phase II Trial
Mostafa El-Haddad
PAJO 2010, 3(3): 26-31
Docetaxel, Cisplatin and Fluorouracil (DCF) versus Epirubicine, Cisplatin & Fluorouracil (ECF) as a first-line therapy in advanced gastric carcinoma patients
Lobna Ezz-Elarab
PAJO 2010, 3(3): 32-37